Open AccessDistinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes
Author(s) -
Sara Fernández,
Ana Belén Moreno-Castaño,
Marta Palomo,
Julia Martinez-Sanchez,
Sergi Torramadé-Moix,
Adrián Téllez,
Helena Ventosa,
Ferran Seguí,
Ginés Escolar,
Enric Carreras,
Josep M. Nicolás,
Edward Richardson,
David GarcíaBernal,
Carmelo CarloStella,
José Marı́a Moraleda,
Paul G. Richardson,
Maribel DíazRicart,
Pedro Castro
Publication year - 2021
Publication title -
shock
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.095
H-Index - 117
eISSN - 1540-0514
pISSN - 1073-2322
DOI - 10.1097/shk.0000000000001823
Subject(s) - medicine , immunology , biomarker , von willebrand factor , sepsis , endothelial activation , thrombomodulin , septic shock , endothelial dysfunction , pneumonia , gastroenterology , platelet , inflammation , biology , thrombin , biochemistry
Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood.